John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$42.9M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$18.9M |
| 3 |
THM
International Tower Hill Mines
THM
|
+$3.25M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.77% |
| 2 | Materials | 31.42% |
| 3 | Financials | 13.25% |
| 4 | Technology | 3.14% |
| 5 | Industrials | 2.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Madrigal Pharmaceuticals
MDGL
$11.9B
| $695M | 39.81% |
2,099,523
+57,523
| +3% | +$18.9M |
|
|
PPTA
2
Perpetua Resources
PPTA
$3.21B
| $265M | 15.16% |
24,771,542
| – | – |
|
|
AAMI
3
Acadian Asset Management
AAMI
$3.28B
| $231M | 13.25% |
8,950,121
| – | – |
|
4
Bausch Health
BHC
$2.41B
| $171M | 9.79% |
26,439,035
| – | – |
|
5
Agnico Eagle Mines
AEM
$109B
| $84.9M | 4.86% |
783,561
| – | – |
|
6
NovaGold Resources
NG
$3.83B
| $79.5M | 4.55% |
27,238,061
| – | – |
|
7
Thryv Holdings
THRY
$92.4M
| $54.8M | 3.14% |
4,280,000
| – | – |
|
|
THM
8
International Tower Hill Mines
THM
$735M
| $44.4M | 2.54% |
70,239,388
+6,040,408
| +9% | +$3.25M |
|
|
9
Honeywell
HON
$68.4B
| $42.4M | 2.42% |
+212,200
| New | +$42.9M |
|
|
SA
10
Seabridge Gold
SA
$3.25B
| $24.2M | 1.38% |
2,070,000
| – | – |
|
|
TMQ
11
Trilogy Metals
TMQ
$684M
| $22.2M | 1.27% |
14,326,996
| – | – |
|
12
Equinox Gold
EQX
$15.8B
| $17.2M | 0.98% |
2,500,000
| – | – |
|
13
IAMGOLD
IAG
$12.1B
| $11.6M | 0.66% |
1,850,000
| – | – |
|
|
ITCI
14
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.84M | 0.16% |
+21,500
| New | +$2.68M |
|
|
15
Alphabet (Google) Class A
GOOGL
$4.22T
| – | – |
-10,000
| Closed | -$1.9M |
|
Similar funds
John Paulson's Q1 2025 Portfolio in Review
As of Q1 2025, John Paulson held 15 positions worth $1.75B, up 5.7% from $1.65B the previous quarter. Its ten largest holdings account for 97% of the portfolio.
John Paulson deployed $65.9M of net new capital in Q1 2025, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Honeywell: 212,200 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 51% a quarter earlier, followed by Materials and Financials.
On the sell side, the most notable exit was Alphabet (Google) Class A, an estimated $1.9M sold.
- John Paulson's largest Q1 2025 buy was Honeywell: 212,200 shares worth $42.4M.
- John Paulson added most to Madrigal Pharmaceuticals in Q1 2025, an estimated $18.9M increase.
- John Paulson fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $1.9M.
- John Paulson's ten largest holdings make up 97% of its $1.75B portfolio in Q1 2025.
- John Paulson opened 2 new positions and closed 1 in Q1 2025.
- John Paulson's portfolio value rose 5.7% quarter-over-quarter to $1.75B.
Based on Paulson & Co's 13F filing for Q1 2025, filed 15 May 2025.